• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Combination and distribution characteristics of syndromes related to traditional Chinese medicine in patients with chronic heart failure: Protocol for a clinical study.慢性心力衰竭患者中医证候的组合与分布特征:一项临床研究方案
Medicine (Baltimore). 2020 Sep 4;99(36):e21852. doi: 10.1097/MD.0000000000021852.
2
[Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method].[慢性充血性心力衰竭证候要素的中医诊疗规律:基于香农熵方法的研究]
Zhong Xi Yi Jie He Xue Bao. 2010 Nov;8(11):1080-4. doi: 10.3736/jcim20101113.
3
Distribution of traditional Chinese medicine syndromes in type 2 diabetes mellitus with chronic heart failure: A clinical study.2型糖尿病合并慢性心力衰竭的中医证候分布:一项临床研究
Medicine (Baltimore). 2020 Jul 24;99(30):e21091. doi: 10.1097/MD.0000000000021091.
4
Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.芪参颗粒治疗慢性心力衰竭患者的安全性和有效性:一项随机对照试验的研究方案
Trials. 2017 Oct 10;18(1):468. doi: 10.1186/s13063-017-2193-z.
5
Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota.通过中医药防治慢性心力衰竭:肠道微生物群的作用。
Pharmacol Res. 2020 Jan;151:104552. doi: 10.1016/j.phrs.2019.104552. Epub 2019 Nov 17.
6
Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study.中药在我国西医院治疗急性心力衰竭中的应用:来自中国心力衰竭前瞻性研究(China PEACE)的分析。
J Am Heart Assoc. 2019 Aug 6;8(15):e012776. doi: 10.1161/JAHA.119.012776. Epub 2019 Jul 31.
7
A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure.中药治疗慢性心力衰竭的研究进展。
Curr Pharm Des. 2017;23(34):5115-5124. doi: 10.2174/1381612823666170925163427.
8
Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.参附注射液负荷量治疗冠心病慢性心力衰竭加重期患者的临床评估:一项随机对照试验的研究方案
Trials. 2015 May 21;16:222. doi: 10.1186/s13063-015-0729-7.
9
[Application and evaluation of Chinese medicine in treatment of chronic heart failure].[中医药在慢性心力衰竭治疗中的应用与评价]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Dec;33(12):1701-4.
10
[Analysis on new research and development ideas and technical points of traditional Chinese medicine for prevention and treatment of chronic heart failure].[中医药防治慢性心力衰竭的新研发思路与技术要点分析]
Zhongguo Zhong Yao Za Zhi. 2020 Jun;45(11):2720-2724. doi: 10.19540/j.cnki.cjcmm.20200107.402.

引用本文的文献

1
Identification and Comparison of Potential Biomarkers by Proteomic Analysis in Traditional Chinese Medicine-Based Heart Failure Syndromes.基于中医心力衰竭证型的蛋白质组学分析对潜在生物标志物的鉴定与比较
Evid Based Complement Alternat Med. 2022 Jan 18;2022:6338508. doi: 10.1155/2022/6338508. eCollection 2022.
2
Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.芪苈强心胶囊联合西药治疗慢性心力衰竭的临床疗效:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2021 Aug 9;2021:9761159. doi: 10.1155/2021/9761159. eCollection 2021.

本文引用的文献

1
Differentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failure.慢性心力衰竭患者胰岛素抵抗状态下胰岛素代谢及血管效应的差异
Am J Cardiol. 2002 Mar 15;89(6):696-703. doi: 10.1016/s0002-9149(01)02342-6.
2
The natural history of congestive heart failure: the Framingham study.充血性心力衰竭的自然病史:弗明汉姆研究
N Engl J Med. 1971 Dec 23;285(26):1441-6. doi: 10.1056/NEJM197112232852601.

慢性心力衰竭患者中医证候的组合与分布特征:一项临床研究方案

Combination and distribution characteristics of syndromes related to traditional Chinese medicine in patients with chronic heart failure: Protocol for a clinical study.

作者信息

Wang Hui, Zhang Jun, Shi Chun-Fen, Jia Jing, Zhang Zhi-Min, Sun Jia-Jia, Lu Bing-Bing

机构信息

Department of Traditional Chinese Medicine, the Majiagou Hospital of Kailuan.

Department of Endocrinology, Tangshan Hospital of Traditional Chinese Medicine, Hebei.

出版信息

Medicine (Baltimore). 2020 Sep 4;99(36):e21852. doi: 10.1097/MD.0000000000021852.

DOI:10.1097/MD.0000000000021852
PMID:32899014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7478826/
Abstract

INTRODUCTION

Chronic heart failure has become one of the main diseases endangering human health in the 21st century. It is characterized by high morbidity and high mortality. With the continuous in-depth study of Traditional Chinese medicine, the treatment of heart failure by Tradional Chinese medicine has made significant progress, especially in improving the clinical symptoms of patients, controlling the development of the disease, and improving the quality of life of patients.

METHODS/DESIGN: This will be a retrospective, single-blind clinical observational study. All participants will receive chronic heart failure routine treatment and care. The researcher will fill in the case information collection form and collect multiple clinical diagnosis and treatment information.

DISCUSSION

At present, there is very little research on the elements of chronic heart failure syndrome, and more exploration and excavation in this area are needed. So we designed this program. We aim to explore the distribution characteristics of Traditional Chinese medicine syndrome elements and combinations of chronic heart failure patients, and analyze the relationship between syndrome elements and related influencing factors.

TRIAL REGISTRATION

ClinicalTrials.gov,ChiCTR2000034555, Registered on 18 May 2020.

摘要

引言

慢性心力衰竭已成为21世纪危害人类健康的主要疾病之一。其特点是发病率高、死亡率高。随着对中医研究的不断深入,中医治疗心力衰竭取得了显著进展,尤其在改善患者临床症状、控制疾病发展以及提高患者生活质量方面。

方法/设计:这将是一项回顾性、单盲临床观察性研究。所有参与者将接受慢性心力衰竭常规治疗和护理。研究人员将填写病例信息收集表并收集多项临床诊疗信息。

讨论

目前,关于慢性心力衰竭证素的研究非常少,该领域需要更多的探索和挖掘。因此我们设计了本方案。我们旨在探讨慢性心力衰竭患者中医证素及证素组合的分布特征,并分析证素与相关影响因素之间的关系。

试验注册

ClinicalTrials.gov,ChiCTR2000034555,于2020年5月18日注册。